Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine:
1. The safety of pemetrexed plus Gemcitabine and any side effects that might be associated
with the combination of these two drugs.
2. Whether pemetrexed plus Gemcitabine can help patients with non-small cell lung cancer
live longer.
3. Whether pemetrexed plus Gemcitabine can make the tumor smaller or disappear, and for how
long.
4. To see if patients feel better while taking pemetrexed plus Gemcitabine.